These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34230226)

  • 1. Ubiquitin D Promotes Progression of Oral Squamous Cell Carcinoma via NF-Kappa B Signaling.
    Song A; Wang Y; Jiang F; Yan E; Zhou J; Ye J; Zhang H; Ding X; Li G; Wu Y; Zheng Y; Song X
    Mol Cells; 2021 Jul; 44(7):468-480. PubMed ID: 34230226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRELP inhibits the progression of oral squamous cell carcinoma via inactivation of the NF-κB pathway.
    Sun X; Chai L; Wang B; Zhou J
    Arch Oral Biol; 2024 Nov; 167():106068. PubMed ID: 39151326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma.
    Chu W; Song X; Yang X; Ma L; Zhu J; He M; Wang Z; Wu Y
    PLoS One; 2014; 9(7):e101931. PubMed ID: 24999732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CARD9 downregulation suppresses the growth of oral squamous cell carcinoma by regulating NF-κB.
    Ye LJ; Zhou XC; Yin XJ; Shang Y; Xiao Y; Jiang YL; Wen XX
    Oral Dis; 2019 Nov; 25(8):1886-1896. PubMed ID: 31306536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-524 suppressed the progression of oral squamous cell carcinoma by suppressing Metadherin and NF-κB signaling pathway in OSCC cell lines.
    Chang XS; Zhu J; Yang T; Gao Y
    Arch Oral Biol; 2021 May; 125():105090. PubMed ID: 33676362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis.
    Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R
    Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CircZDBF2 up-regulates RNF145 by ceRNA model and recruits CEBPB to accelerate oral squamous cell carcinoma progression via NFκB signaling pathway.
    Rong L; Chen B; Liu K; Liu B; He X; Liu J; Li J; He M; Zhu L; Liu K; Shi X; Shuai Y; Jin L
    J Transl Med; 2022 Apr; 20(1):148. PubMed ID: 35365168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma.
    Wang H; Luo Q; Feng X; Zhang R; Li J; Chen F
    BMC Cancer; 2018 May; 18(1):500. PubMed ID: 29716544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Expression of Zinc Finger Protein 703 Promotes Cell Proliferation and Metastasis through PI3K/AKT/GSK-3β Signalling in Oral Squamous Cell Carcinoma.
    Wang H; Deng X; Zhang J; Ou Z; Mai J; Ding S; Huo S
    Cell Physiol Biochem; 2017; 44(3):920-934. PubMed ID: 29176314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Non Coding RNA MALAT1 Promotes Tumor Growth and Metastasis by inducing Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma.
    Zhou X; Liu S; Cai G; Kong L; Zhang T; Ren Y; Wu Y; Mei M; Zhang L; Wang X
    Sci Rep; 2015 Nov; 5():15972. PubMed ID: 26522444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAR1 promotes the epithelial-to-mesenchymal transition and stem-like cell phenotype of oral cancer by facilitating oncogenic microRNA maturation.
    Liu X; Fu Y; Huang J; Wu M; Zhang Z; Xu R; Zhang P; Zhao S; Liu L; Jiang H
    J Exp Clin Cancer Res; 2019 Jul; 38(1):315. PubMed ID: 31315644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UBE2L3 promotes squamous cell carcinoma progression in the oral cavity and hypopharynx via activating the NF-κB signaling by increasing IκBα degradation.
    Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
    Cell Biol Int; 2022 May; 46(5):806-818. PubMed ID: 35128752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. circ_0001461 promotes oral squamous cell carcinoma progression through miR-145/TLR4/NF-κB axis.
    Ai Y; Song J; Wei H; Tang Z; Li X; Lv X; Luo H; Wu S; Zou C
    Biochem Biophys Res Commun; 2021 Aug; 566():108-114. PubMed ID: 34119822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo.
    Furuta H; Osawa K; Shin M; Ishikawa A; Matsuo K; Khan M; Aoki K; Ohya K; Okamoto M; Tominaga K; Takahashi T; Nakanishi O; Jimi E
    Int J Cancer; 2012 Sep; 131(5):E625-35. PubMed ID: 22262470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehydrogenase 1A2 (ALDH1A2).
    Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
    Curr Cancer Drug Targets; 2022; 22(9):771-783. PubMed ID: 35388759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HOXA1 silencing inhibits cisplatin resistance of oral squamous cell carcinoma cells via IκB/NF-κB signaling pathway.
    Zhu R; Mao Y; Xu X; Li Y; Zheng J
    Anticancer Drugs; 2024 Jul; 35(6):492-500. PubMed ID: 38477942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA‑199a‑5p suppresses migration and invasion in oral squamous cell carcinoma through inhibiting the EMT‑related transcription factor SOX4.
    Wei D; Wang W; Shen B; Zhou Y; Yang X; Lu G; Yang J; Shao Y
    Int J Mol Med; 2019 Jul; 44(1):185-195. PubMed ID: 31059001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-146a-5p inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma cells by regulating NF-κB signaling pathway.
    Zhu FY; Gan CW; Wang MX; Sun BC; Li FJ; Qiu YH; Wang K
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3717-3723. PubMed ID: 32329848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
    Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
    PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.